Perrigo's Omega Pharma Struggles In 2018 As It Continues To Restructure And Divest

16 Apr 2019

Perrigo's Europe-focused consumer health business Omega Pharma found sales growth hard to come by in 2018 as the group worked hard to right size the organization. While it still has a way to go to completely turnaround Omega, Perrigo is starting to see these interventions pay off, with profits up for the 12 months.

Nytol Heerbal — Omega Pharma's Nytol Herbal Sleep Aid • Source: Perrigo

Continued efforts by Perrigo Co. PLC to restructure and right-size its Omega Pharma NV consumer health operation hit sales at the Europe-focused business in 2018, with turnover down by 5% for the 12 months.

Perrigo blamed the single-digit slide in Omega’s sales to €988m on the termination of “unprofitable” distribution contracts in Belgium and Portugal, the divestiture of its Russian business to Alvogen Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Recordati Relying On OTC To Act As ‘Booster’ To Growth

15 May 2025

• By Tom Gallen

In categories like cough & cold and gastrointestinal, OTC products have a pivotal role to play in helping Recordati hit its sales targets for the 2025-2027 period.

Bayer Consumer Health Delivers ‘Balanced’ Q1

14 May 2025

• By Tom Gallen

With sales gains across most of its regions and product categories, Bayer Consumer Health got off to a good start to the year.

Mitigating Tariff Impacts, Kenvue Adjusts Outlook

12 May 2025

• By Malcolm Spicer

“The situation has evolved considerably” since Kenvue gave its initial full-year outlook in February, “and remains quite fluid,” says president and CEO Thibaut Mongon as firm reports Q1 net sales decreasing 3.9% to $3.7bn

Looming Tariffs Give Boost To Latest PCH Results While Cutting Costs In Response Takes Priority

09 May 2025

• By Malcolm Spicer

Looming imposition of tariffs by Trump on imports from most every country had an influence on consumers during the January-March period, particularly on online shopping. Increasing product prices on the table, “but our efforts are going to start with cost savings,” says CFO Christine Sacco.

C&D Taps Hand Sanitizer Category With Touchland

13 May 2025

• By Malcolm Spicer

Deal totaling as much as $880m extends C&D into additional product category with a brand it says is the fastest growing in the US hand sanitizer category and No. 2 brand in the category overall.